SCHEMBL278988

SCHEMBL278988

C=C(/N=C/c1cc(Br)ccc1Oc1ccc(C(=O)OC)cc1)O[Si](C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.45
MAPT P10636 9/20 0.41
KMT2A Q03164 9/20 0.40
NPC1 O15118 5/20 0.40
RAB9A P51151 5/20 0.40
KLF5 Q13887 2/20 0.40
LMNA P02545 6/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 3/20 0.39
ALDH1A1 P00352 3/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 6/20 0.39
MEN1 O00255 3/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
GAA P10253 1/20 0.37
MITF O75030 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279086 0.88 MAPT (0.49) CCR5MAPTKMT2ANPC1RAB9A
SCHEMBL278999 0.88 ALDH1A1 (0.39) MAPTKMT2ANPC1RAB9AALDH1A1
SCHEMBL279335 0.88 CA1 (0.36) CCR5MAPTKMT2ANPC1RAB9A
SCHEMBL279092 0.87 CCR5 (0.41) CCR5MAPTKMT2ANPC1RAB9A
SCHEMBL279190 0.87 CCR5 (0.43) CCR5MAPTKMT2ALMNASMN1; SMN2
SCHEMBL279339 0.84 LMNA (0.40) CCR5MAPTKMT2ANPC1RAB9A
SCHEMBL279344 0.81 SLC6A4 (0.46) MAPTKMT2ARAB9ALMNASMN1; SMN2
SCHEMBL276104 0.78 PTGDR2 (0.48) CCR5MAPTKMT2ANPC1RAB9A
SCHEMBL279179 0.77 LMNA (0.44) MAPTLMNAHTTALDH1A1L3MBTL1
SCHEMBL275677 0.77 LMNA (0.44) MAPTLMNAHTTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT CCR5 2331/4885MAPT 4062/4885KMT2A 1329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.